跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Zarnat Plus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Zarnat Plus
Approved
STANDARD
Zarnat Plus
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d3cfa240a9da4269
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
d3cfa240a9da4269
Drug Approval Philippines Name
Zarnat Plus
Product Name
Zarnat Plus
Registration Number
DR-XY37659
Brand Name
Zarnat Plus
Generic Name
Losartan Potasium + Hydrochlorothiazide
Dosage Form
Film-Coated Tablet
Dosage Strength
50 mg/12.5 mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
Corbridge Group Phils., Inc.
Issuance Date
27 October 2024
Expiry Date
19 March 2030
Pharmacologic Category
Angiotensin II Receptor Blocker (ARB) and Diuretic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d3cfa240a9da4269
Type
Standard
Back to Philippines FDA Approvals